Providers
All 16 in CA
PACIFICA LINDA MAR INC.
NPI 1003891516, organization, Pacifica, CA, Skilled Nursing Facility
3
Evidence tier
network structure with a list link
- Part of provider network D1-00041, ranked 41 nationally.
score 60 of 100, rank 2802, $0 at stake
Provider networks
D1-00041 ranked 4177 providers around Riverside, CA: 10 hospices, 29 home health agencies, 38 nursing facilities.
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | PACIFICA LINDA MAR INC. (also LINDA MAR CARE CENTER) |
| Type | Organization |
| Status | Active |
| NPI issued | December 7, 2005, last updated April 5, 2024 |
| Practice location | 751 SAN PEDRO TERRACE RD, Pacifica, CA 94044-4101, 650-359-4800 |
| Mailing address | 25910 ACERO STE 350, Mission Viejo, CA 92691-7908 |
| Authorized official | Marc Johnson (Cfo) |
| Specialties | Skilled Nursing Facility (314000000X, primary, license 220000095 CA) |
In this area
16 providers in San Mateo County, CA carry an indicator in the public record, with $13.5M at stake between them. The most common is part of a provider network, on 10 of them, followed by more hours than a day holds on 5.
| tier | provider | at stake | why |
|---|---|---|---|
| 3 | SUTTER VISITING NURSE ASSOCIATION AND HOSPICE San Mateo, CA, ranked 1426 | $50K |
|
| 3 | SUTTER VISITING NURSE ASSOCIATION AND HOSPICE San Mateo, CA, ranked 1570 | $7K |
|
| 3 | ST JOHNS VOLUNTEERS San Mateo, CA, ranked 2801 | $0 |
|
| 3 | SAN BRUNOIDENCE OPCO, LLC San Bruno, CA, ranked 4019 | $0 |
|
| 3 | PEAR HOLDINGS, LLC Burlingame, CA, ranked 4103 | $0 |
|
| 3 | MUSSEL ROCK HEALTHCARE, INC. Pacifica, CA, ranked 4126 | $0 |
|
| 3 | MILLBRAE CARE CENTER LLC Millbrae, CA, ranked 5544 | $0 |
|
| 3 | CAREMO PLUS LLC San Mateo, CA, ranked 5655 | $0 |
|
Recent enforcement in CA
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
DOJPleaded guiltyAug 27, 2026
Anaheim Woman Pleads Guilty to Submitting More Than $2.2 Million in Fraudulent Hospice Care Claims to Medicare
Galbraith submitted approximately $2,266,694 in claims to Medicare for hospice services for beneficiaries who did not have a terminal illness with a life expectancy of six months or less, and Medicare paid her company approximately $2,140,606.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. submitted claims to Medicare for skin cancer tests conducted with an unvalidated positive control range and for tests lacking sufficient patient RNA, and did not retract results or adequately refund Medicare.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. billed Medicare for skin cancer tests conducted using an unvalidated positive control range and for tests with insufficient patient RNA, and did not retract the results or adequately refund Medicare.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4 Million to Settle False Claims Act Lawsuit
Monogram knowingly submitted diagnosis codes in four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to Medicare Advantage Organizations.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4M to Settle False Claims Act Suit
Monogram Health knowingly submitted diagnosis codes within four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to MAOs.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.